{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:57:34Z","timestamp":1780981054344,"version":"3.54.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Cryptococcal meningitis (CM) is associated with high mortality and neurodevelopmental sequelae and predominantly affects people living with HIV. Screening and pre-emptive treatment for cryptococcal antigen (CrAg) in blood in adults with CD4 &lt;200 cells\/\u00b5L reduces mortality. The World Health Organization does not recommend screening children &lt;10 years due to a presumed low prevalence of CM. Nevertheless, CrAg testing is performed for all ages in South Africa in those with CD4 &lt;100 cells\/\u00b5L.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Children (&lt;18 years) with CD4 &lt;100 cells\/\u00b5L and a CrAg screening result were identified from National Health Laboratory Service records from 2017 to 2022 in South Africa. Fifteen healthcare facilities in Gauteng province were chosen for a convenience sample of CrAg-positive and matched CrAg-negative children to collect detailed clinical information.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Prevalence of cryptococcal antigenemia in South African children &lt;18 years was 4.7% (1352\/28,839) with a median age of 14 years (IQR 11\u201316). CrAg-positive prevalence in children &lt;10 years was 3.5% (261\/7440). Fifty-one CrAg-positive children were included for in-depth chart review. Twenty-four (24\/49; 49%) CrAg-positive children had documented symptoms of meningitis at testing; 33% were diagnosed with CM. Forty-seven percent (8\/17) of CrAg-positive children without documented symptoms developed their first CM episode in the subsequent 12 months. Five percent (1\/19) of CrAg-positive children pre-emptively treated with fluconazole were subsequently diagnosed with CM, compared with 58% (7\/12) of those without a documented prescription (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002). The 6-month mortality for CrAg-positive children was 19% (7\/36). No CrAg-negative children developed CM.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>CrAg prevalence in children with CD4 &lt;100 cells\/\u00b5L is comparable to adults (4.7% and 5.8%, respectively). CrAg screening guidelines should be extended to include all children to improve outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005154","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:00:34Z","timestamp":1769576434000},"page":"623-629","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cryptococcal Antigenemia in South African Children Living With HIV"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2182-5004","authenticated-orcid":false,"given":"Alison","family":"Gifford","sequence":"first","affiliation":[{"name":"Department of Biosciences, Faculty of Life and Health Sciences, MRC Centre for Medical Mycology, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3228-7096","authenticated-orcid":false,"given":"Rudzani","family":"Mashau","sequence":"additional","affiliation":[{"name":"Division of the National Health Laboratory Service, National Institute for Communicable Diseases, Johannesburg, South Africa"},{"name":"Wits Mycology Division, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Mpembe","sequence":"additional","affiliation":[{"name":"Division of the National Health Laboratory Service, National Institute for Communicable Diseases, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Khanyile","sequence":"additional","affiliation":[{"name":"Epicentre Health Research, Johannesburg, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thabo","family":"Maota","sequence":"additional","affiliation":[{"name":"Epicentre Health Research, Johannesburg, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mbali","family":"Dube","sequence":"additional","affiliation":[{"name":"Division of the National Health Laboratory Service, National Institute for Communicable Diseases, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boitumelo","family":"Kgoale","sequence":"additional","affiliation":[{"name":"Division of the National Health Laboratory Service, National Institute for Communicable Diseases, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6586-3358","authenticated-orcid":false,"given":"Adilia","family":"Warris","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Faculty of Life and Health Sciences, MRC Centre for Medical Mycology, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7869-9462","authenticated-orcid":false,"given":"Nelesh P.","family":"Govender","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Faculty of Life and Health Sciences, MRC Centre for Medical Mycology, University of Exeter, Exeter, UK"},{"name":"Division of the National Health Laboratory Service, National Institute for Communicable Diseases, Johannesburg, South Africa"},{"name":"Wits Mycology Division, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"R1-20260609","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/S1473-3099(22)00499-6","article-title":"The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis.","volume":"22","author":"Rajasingham","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"R2-20260609","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease.","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"R5-20260609","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(15)60164-7","article-title":"Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.","volume":"385","author":"Mfinanga","year":"2015","journal-title":"Lancet (Lond)"},{"key":"R6-20260609","first-page":"16","article-title":"Bacterial and fungal meningitis amongst children< 5 years old, South Africa, 2007. FIDSSA Congress abstracts 20 \u2013 23 August 2009.","volume":"23","author":"Meiring","year":"2009","journal-title":"S Afr J Epidemiol Infect"},{"key":"R7-20260609","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/INF.0000000000002396","article-title":"Causes of pediatric meningitis in Botswana: results from a 16-year national meningitis audit.","volume":"38","author":"Mitchell","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20260609","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1097\/QAD.0b013e3283570567","article-title":"A comparison of cases of paediatric-onset and adult-onset cryptococcosis detected through population-based surveillance, 2005\u20132007.","volume":"26","author":"Meiring","year":"2012","journal-title":"AIDS"},{"key":"R9-20260609","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijid.2020.03.068","article-title":"A correlation analysis between clinical manifestations, therapeutic strategies, and the prognosis of children with cryptococcal meningitis in China.","volume":"95","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"R10-20260609","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2217\/fmb-2019-0215","article-title":"Cryptococcal infections in children: retrospective study and review from Australia.","volume":"14","author":"Grimshaw","year":"2019","journal-title":"Future Microbiol"},{"key":"R11-20260609","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/INF.0000000000004216","article-title":"Pediatric cryptococcosis.","volume":"43","author":"Gifford","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"R12-20260609","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3390\/jof11110767","article-title":"Neurological sequelae after paediatric cryptococcal meningitis.","volume":"11","author":"Gifford","year":"2025","journal-title":"J Fungi (Basel)"},{"key":"R15-20260609","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/QAI.0000000000003137","article-title":"Ongoing high prevalence of severe immune suppression among children in South Africa.","volume":"92","author":"Patten","year":"2023","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R17-20260609","first-page":"35","article-title":"2023 ART clinical guidelines for the management of HIV in adults, pregnancy and breastfeeding, adolescents, children, infants and neonates.","volume":"90","author":"Buthelezi","year":"2023","journal-title":"SA Pharm J"},{"key":"R19-20260609","doi-asserted-by":"crossref","first-page":"534","DOI":"10.7196\/SAMJ.2018.v108i7.13094","article-title":"National coverage of reflex cryptococcal antigen screening: a milestone achievement in the care of persons with advanced HIV disease.","volume":"108","author":"Govender","year":"2018","journal-title":"S Afr Med J"},{"key":"R20-20260609","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.4102\/sajhivmed.v20i1.1030","article-title":"Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update.","volume":"20","author":"Govender","year":"2019","journal-title":"S Afr J HIV Med"},{"key":"R22-20260609","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/INF.0000000000002538","article-title":"Serum cryptococcal antigen testing in immunosuppressed HIV-positive children and adolescents.","volume":"39","author":"Zuma","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"R23-20260609","doi-asserted-by":"crossref","first-page":"e0253781","DOI":"10.1371\/journal.pone.0253781","article-title":"Cryptococcal antigen carriage among HIV infected children aged 6 months to 15 years at Laquintinie Hospital in Douala.","volume":"16","author":"Kalla","year":"2021","journal-title":"PLoS One"},{"key":"R24-20260609","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00006454-199705000-00024","article-title":"Rarity of cryptococcal infection in children.","volume":"16","author":"Speed","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"R25-20260609","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.1542\/peds.107.5.e66","article-title":"Serologic evidence for cryptococcus neoformans infection in early childhood.","volume":"107","author":"Goldman","year":"2001","journal-title":"Pediatrics"},{"key":"R26-20260609","doi-asserted-by":"crossref","first-page":"e021506","DOI":"10.1136\/bmjopen-2018-021506","article-title":"Assessing the completeness and accuracy of South African National Laboratory CD4 and viral load data: a cross-sectional study.","volume":"8","author":"Bassett","year":"2018","journal-title":"BMJ Open"},{"key":"R27-20260609","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4102\/ajlm.v7i1.757","article-title":"District and sub-district analysis of cryptococcal antigenaemia prevalence and specimen positivity in KwaZulu-Natal, South Africa.","volume":"7","author":"Cassim","year":"2018","journal-title":"Afr J Lab Med"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:01:27Z","timestamp":1780977687000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005154","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]}}}